JP2011157392A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011157392A5 JP2011157392A5 JP2011087438A JP2011087438A JP2011157392A5 JP 2011157392 A5 JP2011157392 A5 JP 2011157392A5 JP 2011087438 A JP2011087438 A JP 2011087438A JP 2011087438 A JP2011087438 A JP 2011087438A JP 2011157392 A5 JP2011157392 A5 JP 2011157392A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- total weight
- composition according
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- 208000029433 Herpesviridae infectious disease Diseases 0.000 claims 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims 1
- 229960004150 aciclovir Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960000890 hydrocortisone Drugs 0.000 claims 1
- -1 isopropyl ester Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
- 239000007764 o/w emulsion Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803929A SE9803929D0 (sv) | 1998-11-18 | 1998-11-18 | Antiviral formulation |
| SE9803929-0 | 1998-11-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000582073A Division JP2002529520A (ja) | 1998-11-18 | 1999-11-12 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011157392A JP2011157392A (ja) | 2011-08-18 |
| JP2011157392A5 true JP2011157392A5 (https=) | 2012-12-06 |
| JP5420583B2 JP5420583B2 (ja) | 2014-02-19 |
Family
ID=20413320
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000582073A Pending JP2002529520A (ja) | 1998-11-18 | 1999-11-12 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
| JP2011087438A Expired - Lifetime JP5420583B2 (ja) | 1998-11-18 | 2011-04-11 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000582073A Pending JP2002529520A (ja) | 1998-11-18 | 1999-11-12 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1131104B1 (https=) |
| JP (2) | JP2002529520A (https=) |
| KR (1) | KR100608963B1 (https=) |
| CN (1) | CN1160128C (https=) |
| AR (1) | AR023705A1 (https=) |
| AT (1) | ATE288283T1 (https=) |
| AU (1) | AU772435B2 (https=) |
| CA (1) | CA2351463C (https=) |
| DE (1) | DE69923584T2 (https=) |
| DK (1) | DK1131104T3 (https=) |
| EG (1) | EG23853A (https=) |
| ES (1) | ES2233104T3 (https=) |
| HK (1) | HK1042440B (https=) |
| IL (2) | IL142702A0 (https=) |
| MY (1) | MY122397A (https=) |
| NZ (1) | NZ511832A (https=) |
| PT (1) | PT1131104E (https=) |
| SE (1) | SE9803929D0 (https=) |
| TW (1) | TW589191B (https=) |
| WO (1) | WO2000029027A1 (https=) |
| ZA (1) | ZA200103335B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003043628A1 (de) | 2001-11-19 | 2003-05-30 | Medigene Aktiengesellschaft | Arzneimittel zur behandlung von viralen haut- und tumorerkrankungen |
| BRPI0415215B8 (pt) | 2003-10-09 | 2021-05-25 | Medigene Ag | uso de polifenol na preparação de medicamento |
| JP4972062B2 (ja) * | 2008-03-17 | 2012-07-11 | メディヴィル・アクチエボラーグ | 抗ウイルス製剤 |
| EP3836934B1 (en) * | 2018-08-17 | 2023-06-21 | Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi | Phase stable topical composition comprising acyclovir and hydrocortisone |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW438585B (en) * | 1995-02-06 | 2001-06-07 | Astra Ab | Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections |
| US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
-
1998
- 1998-11-18 SE SE9803929A patent/SE9803929D0/xx unknown
-
1999
- 1999-11-12 NZ NZ511832A patent/NZ511832A/en not_active IP Right Cessation
- 1999-11-12 DK DK99972109T patent/DK1131104T3/da active
- 1999-11-12 KR KR1020017006232A patent/KR100608963B1/ko not_active Expired - Fee Related
- 1999-11-12 WO PCT/SE1999/002043 patent/WO2000029027A1/en not_active Ceased
- 1999-11-12 ES ES99972109T patent/ES2233104T3/es not_active Expired - Lifetime
- 1999-11-12 JP JP2000582073A patent/JP2002529520A/ja active Pending
- 1999-11-12 AT AT99972109T patent/ATE288283T1/de active
- 1999-11-12 PT PT99972109T patent/PT1131104E/pt unknown
- 1999-11-12 CN CNB998133825A patent/CN1160128C/zh not_active Expired - Lifetime
- 1999-11-12 IL IL14270299A patent/IL142702A0/xx active IP Right Grant
- 1999-11-12 CA CA002351463A patent/CA2351463C/en not_active Expired - Lifetime
- 1999-11-12 DE DE69923584T patent/DE69923584T2/de not_active Expired - Lifetime
- 1999-11-12 AU AU14364/00A patent/AU772435B2/en not_active Expired
- 1999-11-12 HK HK02104279.2A patent/HK1042440B/zh not_active IP Right Cessation
- 1999-11-12 EP EP99972109A patent/EP1131104B1/en not_active Expired - Lifetime
- 1999-11-15 TW TW088119865A patent/TW589191B/zh not_active IP Right Cessation
- 1999-11-16 MY MYPI99004979A patent/MY122397A/en unknown
- 1999-11-16 EG EG146899A patent/EG23853A/xx active
- 1999-11-17 AR ARP990105846A patent/AR023705A1/es active IP Right Grant
-
2001
- 2001-04-19 IL IL142702A patent/IL142702A/en not_active IP Right Cessation
- 2001-04-24 ZA ZA200103335A patent/ZA200103335B/en unknown
-
2011
- 2011-04-11 JP JP2011087438A patent/JP5420583B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016538271A5 (https=) | ||
| WO2011113013A3 (en) | Methods and compositions for treating viral or virally-induced conditions | |
| WO2014078778A3 (en) | Antiviral azasugar-containing nucleosides | |
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| ECSP13012546A (es) | Formulación tópica para un inhibidor de jak | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| CA2862755A1 (en) | Antiviral compounds with a dibenzooxaheterocycle moiety | |
| ME02321B (me) | Antivirusna jedinjenja | |
| JP2016512248A5 (https=) | ||
| CL2012001836A1 (es) | Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros. | |
| HRP20171512T1 (hr) | Derivati betulina | |
| HRP20200836T1 (hr) | Liječenje bolesti povezanih s imunitetom i upalnih bolesti | |
| IL295418B1 (en) | Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus | |
| ECSP13012467A (es) | Uso de aglutinantes para fabricar formulaciones estables al almacenamiento | |
| HK1209638A1 (en) | Pharmaceutical compositions | |
| WO2013123138A3 (en) | Spiro [2.4]heptanes for treatment of flaviviridae infections | |
| WO2011019326A3 (en) | Solubility and stability enchancing pharmaceutical formulation | |
| JP2014533681A5 (https=) | ||
| JP2011157392A5 (https=) | ||
| HK1206621A1 (en) | Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof | |
| JP2014062109A5 (https=) | ||
| JP2009221186A5 (https=) | ||
| HRP20221344T1 (hr) | Novi pripravak acetaminofenskog spoja bez nuspojave po jetru | |
| JP2017513944A5 (https=) | ||
| JP2008088189A5 (https=) |